Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Letícia Paula Leonart"'
Autor:
Thabata Martins Ferreira Campuzano, Maria Amelia Carlos Souto Maior Borba, Paula de Mendonça Batista, Michelle Nadalin, Cicera Pimenta Marcelino, Paula Cristina Pungartnik, Angélica Carreira Dos Santos, Letícia Paula Leonart Garmatter, Maria Aparecida do Carmo Rego, Angélica Nogueira-Rodrigues
Publikováno v:
PLoS ONE, Vol 19, Iss 10, p e0312757 (2024)
The aim of the study is to evaluate the treatment patterns, time to start treatment, and healthcare resources utilization (HCRU) of cervical cancer (CC) patients within the Brazilian public health system (SUS). This is an observational retrospective
Externí odkaz:
https://doaj.org/article/f8d341a60c464e6f92c8c151dcbfa919
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 26, Iss , Pp 101781- (2022)
Introdução: A facilidade de uso e o tempo de resposta rápido dos testes de antígenos oferecem o potencial da sua realização de forma descentralizada e a expansão do acesso ao diagnóstico, possibilitando a interrupção da transmissão por mei
Externí odkaz:
https://doaj.org/article/90da29f8314b4941a412a2cad0888b7f
Autor:
Astrid Wiens, Helena Hiemisch Lobo Borba, Letícia Paula Leonart, Fernanda Stumpf Tonin, Laiza Maria Steimbach, Ariane Gonçalves Silva de Araújo, Thais Piazza, Vinicius Lins Ferreira, Roberto Pontarolo
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 54, Iss 4 (2019)
The aim of this study was to evaluate interruption of treatment with biological drugs and tofacitinib due to adverse events in patients with rheumatoid arthritis. A systematic review was performed in the electronic databases MEDLINE, Cochrane, Scopus
Externí odkaz:
https://doaj.org/article/a95405c99a864032922e33a4ee11483f
Autor:
Mariana Millan Fachi, Letícia Bonancio Cerqueira, Letícia Paula Leonart, Thais Martins Guimarães de Francisco, Roberto Pontarolo
Publikováno v:
PLoS ONE, Vol 11, Iss 12, p e0167107 (2016)
An ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry method for the simultaneous quantification of chlorpropamide, glibenclamide, gliclazide, glimepiride, metformin, nateglinide, pioglitazone, rosiglitazone, and vild
Externí odkaz:
https://doaj.org/article/64b0b5dea17e475b8ef51f7fd7eff4f0
Autor:
Letícia Paula Leonart, João Cleverson Gasparetto, Flávia Lada Degaut Pontes, Letícia Bonancio Cerqueira, Thais Martins Guimarães de Francisco, Roberto Pontarolo
Publikováno v:
Molecules, Vol 22, Iss 11, p 2031 (2017)
Coumarin (1,2-benzopyrone) is a natural compound whose metabolism in humans was established in the 1970s. However, a new metabolite was recently identified in human plasma, indicating that the metabolism of coumarin has not been completely elucidated
Externí odkaz:
https://doaj.org/article/1d4ece56527443d9896e8aef5b6e827f
Autor:
Campuzano, Thabata Martins Ferreira, Borba, Maria Amelia Carlos Souto Maior, de Mendonça Batista, Paula, Nadalin, Michelle, Marcelino, Cicera Pimenta, Pungartnik, Paula Cristina, dos Santos, Angélica Carreira, Garmatter, Letícia Paula Leonart, Rego, Maria Aparecida do Carmo, Nogueira-Rodrigues, Angélica
Publikováno v:
PLoS ONE; 10/30/2024, Vol. 19 Issue 10, p1-18, 18p
A Systematic Review and Meta-analyses of Longitudinal Studies on Drug Treatments for Gaucher Disease
Autor:
Letícia Paula Leonart, Mariana M. Fachi, Beatriz Böger, Mariana Ribeiro da Silva, Renata Szpak, Natália Fracaro Lombardi, Maria Lucia Alves Pedroso, Roberto Pontarolo
Publikováno v:
Annals of Pharmacotherapy. 57:267-282
Objective: Gaucher disease (GD) is a rare disorder linked to the absence/deficiency of glucocerebrosidase. GD can be treated by enzyme replacement therapy (ERT) and substrate reduction therapy (SRT). The aim of this systematic review (SR) is to asses
Publikováno v:
In Brazilian Journal of Infectious Diseases January 2022 26 Supplement 1
Autor:
Ramon Missias- Moreira, Luís Manuel Mota Sousa, Olga Sousa Valentim, Helena Maria Guerreiro José, Adriana Leônidas de Oliveira, Aimê Cunha, Alana Marques Cordeiro, Alexandre de Fátima Cobre, Aline Bichels, Amanda Felipe Portella, Amanda Magnanti, Ana Caroline de Paula, Ana Vanessa Antunes, Andréa Krawutschke Iera, Andressa Leal Zambra, Beatriz Böger, Bruna Ferreira da Silva, Bruna Rabaioli de Oliveira, Camila Maçalai, Carla Alexandra Correia da Silva, Caroline Gonçalves Pustiglione Campos, Cinthia Fernanda da Fonseca Silva, Cláudia Jorge de Sousa Oliveira, Cristiana Furtado Firmino, Cristina Berger Fadel, Cristina Maria Alves Marques- Vieira, Danielle Bordin, Diego Pires Cruz, Domingos Sávio Teixeira Geraldo, Eduarda Valim Pereira, Erildo Vicente Muller, Fabiano Nazar, Fabio Ricardo Hilgenberg Gomes, Fátima Frade, Gabriela Bonfanti- Azzolin, Gislaine Cristina Vagetti, Gláucia Alexandre Formozo, Paulo Jorge Pereira Alves, Janaina Coser, Janaína da Silva Bett, Janice de Fátima Pavan Zanella, Joni Marcio de Farias, Julia Casagrande Bitencourt, Juliette Heringer Vianna, Leandro de Moraes Kohl, Lessa da Costa, Letícia Paula Leonart Garmatter, Lia da Porciuncula Dias da Costa, Luana Suemi Fujita, Luciana Elisabete Savaris, Luciane Patrícia Andreani Cabral, Mariana Millan Fachi, Luiz Felipe Kruel Borges, Madalena Rotta, Magali Kellermann da Silva, Marta Regina Soares de Assunção, Milene Zanoni da Silva, Naiane Leal Abreu, Paulo Cesar Lopes Silva, Paulo Ricardo Moreira, Paulo Vitor Alves de Farias, Priscila d’Almeida Ferreira, Quésia Postigo Kamimura, Reginaldo Thuler Torres, Renata Szpak, Roberta Cattaneo Horn, Roberto Pontarolo, Ronan Possamai Martins, Sandriane Aparecida Kalamar Martins, Susana Isabel Mendes Pinto, Tânia Sofia Martins Gonçalves, Tatiane Dräger Dal Ponte Pinheiro, Thaís Gomes Santos Pires, Valdomiro de Oliveira
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee04e562a64c90617cc7438c9946d687
https://doi.org/10.24824/978854443472.7
https://doi.org/10.24824/978854443472.7
Publikováno v:
Revista da Sociedade Brasileira de Medicina Tropical, Vol 53 (2020)
Abstract INTRODUCTION We conducted a cost-utility analysis of available interferon-free treatments for patients with early-stage genotype 1 chronic hepatitis C based on a Brazilian public health system perspective. METHODS A Markov model was derived
Externí odkaz:
https://doaj.org/article/1a8cdbed73894bb282a90ee5a3b422ed